Syschem (India) Limited
BSE: SYSCHEM
Prev Close
45.32
Open Price
44.41
Volume
2,163
Today Low / High
44.41 / 47.44
52 WK Low / High
35.33 / 62
Range
44 - 49
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 46.58, reflecting a change of 1.26 (2.78023%). The expected target range on the BSE is 44 - 49. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Syschem (India) Limited Graph
Syschem (India) Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Syschem (India) Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 46.58, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 46.58 | 47.05 | 42.34 - 51.75 |
| 47.51 | 38.01 - 57.01 | ||
| 47.98 | 33.58 - 62.37 | ||
| Bearish Scenario | 46.58 | 46.11 | 41.50 - 50.73 |
| 45.65 | 36.52 - 54.78 | ||
| 45.18 | 31.63 - 58.74 |
Overview of Syschem (India) Limited
ISIN
INE121D01036
Industry
Medical - Pharmaceuticals
Vol.Avg
30,070
Market Cap
2,078,616,010
Last Dividend
0
Official Website
IPO Date
2003-01-15
DCF Diff
80.97
DCF
-24
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 386.23 Cr | 307.22 Cr | 79.01 Cr | 0.2046 | 0.00 Cr | 8.41 Cr | 70.76 Cr | 0.46 Cr | 0.11 | 3.98 Cr | 0.0012 |
| 2024-03-31 | 233.53 Cr | 176.63 Cr | 56.90 Cr | 0.2437 | 0.00 Cr | 6.26 Cr | 50.49 Cr | 2.76 Cr | 0.78 | 7.11 Cr | 0.0118 |
| 2023-03-31 | 130.28 Cr | 98.67 Cr | 14.78 Cr | 0.1135 | 0.00 Cr | 0.75 Cr | 5.94 Cr | 4.51 Cr | 1.53 | 8.85 Cr | 0.0346 |
| 2022-03-31 | 65.50 Cr | 51.93 Cr | -0.05 Cr | -0.0007 | 0.00 Cr | 0.83 Cr | -1.90 Cr | -1.71 Cr | -0.69 | 0.69 Cr | -0.0261 |
| 2021-03-31 | 68.18 Cr | 66.65 Cr | 1.53 Cr | 0.0225 | 0.00 Cr | 1.10 Cr | -7.17 Cr | -5.57 Cr | -2.48 | -4.90 Cr | -0.0816 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.14 Cr | 217.26 Cr | 125.97 Cr | 91.2879 Cr | 0.00 Cr | -2.14 Cr | 68.28 Cr | 53.40 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 124.0540 Cr |
| 2024-03-31 | 0.10 Cr | 164.03 Cr | 107.07 Cr | 56.9564 Cr | 0.45 Cr | 0.35 Cr | 51.40 Cr | 34.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 96.7717 Cr |
| 2023-03-31 | 0.57 Cr | 92.71 Cr | 70.41 Cr | 22.3046 Cr | 1.61 Cr | 1.03 Cr | 15.52 Cr | 30.80 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 42.9751 Cr |
| 2022-03-31 | 0.03 Cr | 59.81 Cr | 52.87 Cr | 6.9416 Cr | 1.75 Cr | 1.72 Cr | 19.14 Cr | 31.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 25.5402 Cr |
| 2021-03-31 | 0.02 Cr | 77.17 Cr | 70.05 Cr | 7.1238 Cr | 15.22 Cr | 15.19 Cr | 33.26 Cr | 30.55 Cr | 1.40 Cr | 0.00 Cr | 0.00 Cr | 40.8907 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -10.0938 Cr | -21.6707 Cr | 33.8053 Cr | -31.8130 Cr | 2.0408 Cr | 2.1365 Cr | -21.7192 Cr | 0.4601 Cr | 0.0000 Cr | 0.0000 Cr | -16.8816 Cr |
| 2024-03-31 | -25.6481 Cr | -6.4649 Cr | 31.6378 Cr | -32.3305 Cr | -0.4752 Cr | 0.0957 Cr | -6.6824 Cr | 2.7614 Cr | 0.0000 Cr | 0.0000 Cr | -35.8788 Cr |
| 2023-03-31 | -8.4950 Cr | 9.0805 Cr | 10.6880 Cr | -10.4531 Cr | 0.5435 Cr | 0.5709 Cr | -1.9581 Cr | 6.1507 Cr | 0.0000 Cr | 0.0000 Cr | 3.6192 Cr |
| 2022-03-31 | 1.0699 Cr | -0.7824 Cr | -0.2842 Cr | -3.3432 Cr | 0.0033 Cr | 0.0274 Cr | -4.4131 Cr | -2.1732 Cr | 0.0000 Cr | 0.0000 Cr | 14.1227 Cr |
| 2021-03-31 | 3.7181 Cr | -3.7743 Cr | -0.0554 Cr | -1.3905 Cr | -0.1114 Cr | 0.0241 Cr | -5.1086 Cr | -7.3149 Cr | 0.0000 Cr | 0.0000 Cr | -12.7331 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 141.50 Cr | 132.58 Cr | 8.92 Cr | 0.0630 | 5.14 Cr | 4.17 Cr | 0.96 | 5.96 Cr | 0.0295 |
| 2025-09-30 | 103.60 Cr | 95.94 Cr | 7.67 Cr | 0.0740 | 2.55 Cr | 1.90 Cr | 0.44 | 3.31 Cr | 0.0183 |
| 2025-06-30 | 109.32 Cr | 103.59 Cr | 5.73 Cr | 0.0524 | 1.71 Cr | 1.67 Cr | 0.38 | 2.47 Cr | 0.0153 |
| 2025-03-31 | 118.87 Cr | 104.87 Cr | 68.55 Cr | 0.5767 | 0.99 Cr | 0.46 Cr | 0.11 | 1.73 Cr | 0.0039 |
| 2024-12-31 | 77.76 Cr | 72.80 Cr | 4.97 Cr | 0.0639 | 0.52 Cr | 0.50 Cr | 0.13 | 1.22 Cr | 0.0065 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 4.41 Cr | 0.00 Cr | 4.41 Cr | 69.70 Cr | 41.32 Cr | 117.12 Cr | 62.81 Cr | 182.06 Cr | 87.20 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 2.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -91.29 Cr |
| 2025-03-31 | 2.14 Cr | 0.00 Cr | 2.14 Cr | 89.54 Cr | 68.28 Cr | 161.43 Cr | 53.40 Cr | 217.26 Cr | 125.97 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.10 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -56.45 Cr |
| 2024-09-30 | 0.09 Cr | 0.01 Cr | 0.10 Cr | 32.53 Cr | 31.72 Cr | 65.00 Cr | 49.18 Cr | 117.18 Cr | 60.73 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 1.67 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 0.46 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 0.50 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 0.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2023-09-28 | September 28, 23 | 136:125 |
| 2014-12-12 | December 12, 14 | 1:10 |
| 2003-04-22 | April 22, 03 | 10:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹830.35 | ₹99,644,807,413.00 | ₹76,499.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born: 1974
Gender: female
Year Born:
Gender: male
Year Born: 1966
FAQs about Syschem (India) Limited
The CEO is Ranjan Jain.
The current price is ₹47.77.
The range is ₹35.33-62.
The market capitalization is ₹207.86 crores.
The P/E ratio is 25.34.
The company operates in the Healthcare sector.
Overview of Syschem (India) Limited (ISIN: INE121D01036) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹207.86 crores and an average daily volume of 30,070 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.